Glucocorticoid-mediated/JJ
repression/NN
of/IN
cytokine/NN
gene/NN
transcription/NN
in/IN
human/JJ
arteritis-SCID/NN
chimeras/NNS
./.

Giant/JJ
cell/NN
arteritis/NN
(/(
GCA/NN
)/)
is/VBZ
a/DT
vasculitic/JJ
syndrome/NN
that/WDT
preferentially/RB
affects/VBZ
medium/NN
and/CC
large-sized/JJ
arteries/NNS
./.
=====
Glucocorticoid/NN
therapy/NN
resolves/VBZ
clinical/JJ
symptoms/NNS
within/IN
hours/NNS
to/TO
days/NNS
,/,
but/CC
therapy/NN
has/VBZ
to/TO
be/VB
continued/VBN
over/IN
several/JJ
years/NNS
to/TO
prevent/VB
disease/NN
relapses/NNS
./.
=====
It/PRP
is/VBZ
not/RB
known/VBN
whether/IN
and/CC
how/WRB
glucocorticoids/NNS
affect/VBP
the/DT
function/NN
of/IN
the/DT
inflammatory/JJ
infiltrate/NN
or/CC
why/IN
the/DT
disease/NN
persists/VBZ
subclinically/RB
despite/IN
chronic/JJ
treatment/NN
./.
=====
GCA/NN
is/VBZ
self-sustained/JJ
in/IN
temporal/JJ
arteries/NNS
engrafted/VBN
into/IN
SCID/NN
mice/NNS
,/,
providing/VBG
a/DT
model/NN
in/IN
which/WDT
the/DT
mechanisms/NNS
of/IN
action/NN
and/CC
limitations/NNS
of/IN
glucocorticoid/NN
therapy/NN
can/MD
be/VB
examined/VBN
in/FW
vivo/FW
./.
=====
Administration/NN
of/IN
dexamethasone/NN
to/TO
temporal/JJ
artery-SCID/NN
chimeras/NNS
for/IN
1/CD
wk/NN
induced/VBD
a/DT
partial/JJ
suppression/NN
of/IN
T/NN
cell/NN
and/CC
macrophage/NN
function/NN
as/IN
indicated/VBN
by/IN
the/DT
reduced/VBN
tissue/NN
concentrations/NNS
of/IN
IL-2/NN
,/,
IL-1beta/NN
,/,
and/CC
IL-6/NN
mRNA/NN
,/,
and/CC
by/IN
the/DT
diminished/VBN
expression/NN
of/IN
inducible/JJ
NO/NN
synthase/NN
./.
=====
In/IN
contrast/NN
,/,
synthesis/NN
of/IN
IFN-gamma/NN
mRNA/NN
was/VBD
only/RB
slightly/RB
decreased/VBN
,/,
and/CC
expression/NN
of/IN
TGF-beta1/NN
was/VBD
unaffected/JJ
./.
=====
These/DT
findings/NNS
correlated/VBD
with/IN
activation/NN
of/IN
the/DT
IkappaBalpha/NN
gene/NN
and/CC
blockade/NN
of/IN
the/DT
nuclear/JJ
translocation/NN
of/IN
NFkappaB/NN
in/IN
the/DT
xenotransplanted/VBN
tissue/NN
./.
=====
Dose-response/JJ
experiments/NNS
suggested/VBD
that/IN
steroid/NN
doses/NNS
currently/RB
used/VBN
in/IN
clinical/JJ
medicine/NN
are/VBP
suboptimal/JJ
in/IN
repressing/VBG
NFkappaB-mediated/JJ
cytokine/NN
production/NN
in/IN
the/DT
inflammatory/JJ
lesions/NNS
./.
=====
Chronic/JJ
steroid/NN
therapy/NN
was/VBD
able/JJ
to/TO
deplete/VB
the/DT
T/NN
cell/NN
products/NNS
IL-2/NN
and/CC
IFN-gamma/NN
,/,
whereas/IN
the/DT
activation/NN
of/IN
tissue-infiltrating/JJ
macrophages/NNS
was/VBD
only/RB
partially/RB
affected/VBN
./.
=====
IL-1beta/NN
transcription/NN
was/VBD
abrogated/VBN
;/:
in/IN
contrast/NN
,/,
TGF-beta1/NN
mRNA/NN
synthesis/NN
was/VBD
steroid/NN
resistant/JJ
./.
=====
The/DT
persistence/NN
of/IN
TGF-beta1-transcribing/JJ
macrophages/NNS
,/,
despite/IN
paralysis/NN
of/IN
T/NN
cell/NN
function/NN
,/,
may/MD
provide/VB
an/DT
explanation/NN
for/IN
the/DT
chronicity/NN
of/IN
the/DT
disease/NN
,/,
and/CC
may/MD
identify/VB
a/DT
novel/JJ
therapeutic/JJ
target/NN
in/IN
this/DT
inflammatory/JJ
vasculopathy/NN
./.